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The important role of genetics in pediatric illness has been increasingly recognized, but the true impact has not
been well delineated. An important study of pediatric inpatient admissions to a children’s hospital in 1978 found
a genetic basis for disease in just less than half of admitted patients. We sought to update this study in light of
current hospitalization practices and new knowledge about genetics. We systematically reviewed the records of
5,747 consecutive admissions (4,224 individuals), representing 98% of patients admitted in 1996 to Rainbow
Babies and Children’s Hospital (Cleveland, OH). Each patient was assigned to one of five groups on the basis of
the presence or absence of an underlying chronic medical condition and whether that condition had a genetic basis
or susceptibility. An underlying disorder with a significant genetic component was found in 71% of admitted
children. The vast majority (96%) of underlying chronic disorders in children in this study were either clearly
genetic or had a genetic susceptibility. Total charges for 1996 were 1$62 million, of which $50 million (81%) was
accounted for by disorders with a genetic determinant. The 34% of admissions with clearly genetic underlying
disorders accounted for 50% (1$31 million) of the total hospital charges. The mean length of stay was 40% longer
for individuals with an underlying disease with a genetic basis than for those with no underlying disease. Charges
and length of stay were similar for children with underlying chronic disorders, regardless of the cause. This study
begins to quantify the enormous impact of genetic disease on inpatient pediatrics and the health care system.
Additional study and frank public discourse are needed to understand the implications on the future health care
workforce and on the utilization of health care resources.
Introduction
Individual genetic disorders are rare, but, in the aggre-
gate, genetic disorders are common. One of the recurring
themes of the era of the Human Genome Project is the
growing recognition of the complexity of the genetic and
molecular basis of disease. Accumulating evidence even
suggests that susceptibility to infections and disorders
like hemolytic uremic syndrome may be genetically de-
termined (Rougier et al. 1998; Noris et al. 1999). An
annual review of pediatric mortality data shows that 23%
of infant deaths are due to genetically determined dis-
orders (Hoyert et al. 2001). In a study from Scotland
published in 1991, as many as 70% of children who were
admitted to a pediatric intensive care unit had partly or
wholly genetically determined disorders (FitzPatrick et al.
1991). In the past 30 years, a variety of investigators,
utilizing different approaches, have examined the burden
of genetic disease and congenital anomalies in samples of
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inpatients of all ages (Day and Holmes 1973), in neonatal
intensive care settings (Ling et al. 1991; Ling 1992), in
pediatric intensive care settings (FitzPatrick et al. 1991;
Cunniff et al. 1995), among pediatric inpatients (Scriver
et al. 1973; Hall et al. 1978; Carnevale et al. 1985; Yoon
et al. 1997), and in a large cohort of consecutively born
children (Chung and Myrianthopoulos 1987). More than
25 years ago, Hall et al. (1978) performed a landmark
study of 4,100 admissions to a pediatric hospital, finding
that just over half were for a genetically determined con-
dition, with 4.5% being due to wholly genetic disorders,
22% due to multifactorial or polygenic disorders, and
27% due to developmental or familial disorders. Patients
with genetically determined disorders stayed in the hos-
pital longer and had more expensive admissions.
Changes in health care delivery in the past 25 years,
especially trends toward outpatient care of uncompli-
cated problems and a greater understanding of the ge-
netic basis of many disorders, may lead to a higher
proportion of genetic disease among pediatric inpa-
tients. We recently conducted a study of the burden of
genetic disease similar to that of Hall et al. in a pediatric
inpatient population. Specifically, we set out to deter-
mine the proportion of pediatric admissions with an
underlying chronic condition and what proportion of
those have a genetic determinant.
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Figure 1 Flowchart of the record-evaluation process
Table 1
Definitions of Categories
Category Definition Examples
I Underlying conditions with strong genetic basis
I-A Single-gene or chromosomal Cystic fibrosis, sickle cell disease, chromosome anomaly
I-B Multifactorial/polygenic Congenital heart disease, cleft lip/palate, Hirschsprung disease
I-C Heterogeneous causes, often genetic Mental retardation, seizures
II Birth defects without known genetic basis
II-A Malformations of unknown etiology Bladder exstrophy
II-B Teratogenic disorders Congenital cytomegaloviral infection, fetal alcohol-related disorder
III Acquired disorders with genetic predisposition Asthma, diabetes, cancer
IV Acquired disorders without genetic determinant Hypoxic-ischemic brain injury
V No preexisting chronic medical condition Acute trauma or infection in previously healthy child
Subjects and Methods
The study was performed at Rainbow Babies and Chil-
dren’s Hospital (Cleveland, OH), a full-service children’s
hospital with 244 pediatric inpatient beds. The hospital
is part of University Hospitals of Cleveland, and its pa-
tient population includes primary care for many parts
of Cleveland, as well as tertiary care for northeastern
OH. The protocol was reviewed and approved by the
institutional review board. We reviewed the records of
every child 18 years of age admitted in calendar year
1996, the latest year for which complete discharge re-
cords were available and computerized at the time the
study began. A computerized database capturing a va-
riety of demographic, medical, and financial data for
each admission was maintained by the health informa-
tion service at University Hospitals of Cleveland. These
records formed the initial database for this study.
Figure 1 shows a flowchart of the study’s design. Preg-
nancy-related diagnoses, including deliveries, newborn
care, and neonatal intensive care, were excluded because
the purpose of the study was to evaluate children ad-
mitted to a pediatric inpatient unit. All other children
18 years of age were included. Each patient’s record
was reviewed until a genetic diagnosis was identified or
eliminated. Each admission was assigned to a category
on the basis of the presence or absence of an underlying
disorder, whether or not it was the proximate cause of
the admission, and the extent to which that disorder
was genetically determined.
Table 1 shows the categories used, definitions, and
examples of each category. A complete list of the as-
signed diagnoses in each category is available as an on-
line supplement (appendix A). These categories were
modified from those defined by Hall et al. (1978), to
allow for increased recognition of the genetic contri-
bution to various chronic medical conditions. Category
I includes individuals with a congenital underlying con-
dition, with various subcategories designed to further
refine the genetic component. Category II includes in-
dividuals with birth defects that are not known to have
a genetic basis, including teratogenic effects. It should
be noted that this classification does not imply that pos-
sible genetic causes have been disproved, only that cur-
rent evidence is not strong for an underlying genetic
cause. Category III includes individuals with those ac-
quired disorders for which the medical literature and
clinical experience suggest a genetic component, pre-
disposition, or genetically determined susceptibility.
Category IV includes individuals with an acquired
chronic underlying condition with no recognized genetic
component. Category V includes those children with no
preexisting chronic medical condition of any kind (ge-
netic or nongenetic)—that is, previously healthy chil-
dren admitted for an acute illness or injury.
The initial review, using only the discharge diagnoses
listed in the computerized database, identified those in-
patients with an underlying disorder that was clearly
genetically determined, such as trisomy 21 or cystic fi-
brosis. These diagnoses were assigned to category I-A
(see table 1). The second level of review looked at com-
puterized discharge summaries for those admissions
that could not be assigned to category I-A on the basis
of discharge diagnoses alone; additional documentation
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Table 2
Comparison of Data from Charts That Were Not Available with Data from All Available Charts
CHART
AVERAGE VALUE (95% CI)
Daily Charge Length of Stay [d] Age [d]
Not available ( )np 112 $14,939 ($5,507–$24,370) 5.33 (2.61–8.05) 1,705 (1,368–2,042)
All others ( )np 5,635 $10,837 ($10,008–$11,665) 4.77 (4.49–5.05) 2,523 (2,465–2,581)
of a clearly genetic disorder was sought so that the chart
could be assigned to the most appropriate category. For
all records that could not be assigned to category I-A
from the discharge diagnoses or the discharge summary,
the entire written medical chart was manually reviewed,
abstracted, and systematically evaluated. This review of
the written record included all previous admissions and
available outpatient-clinic notes. Categories were as-
signed on the basis of the presence and etiology of any
underlying chronic medical condition in the admitted
patient. The charts were abstracted by one of three re-
search associates. Assignment of a particular diagnosis
to a category was made by one of the medical geneticists
(S.B.C. or S.E.M.). The research associate assigned ad-
ditional occurrences of the same diagnosis to the pre-
viously determined category without review by the med-
ical geneticists. In many cases, a diagnosis could not
easily be assigned to a category. The research associate
and the two geneticists conferred on those cases in de-
tail, and assignment was made using available resources,
such as Mendelian Inheritance in Man, both the online
(OMIM) and bound versions (McKusick 1998).
Yoon et al. (1997) generated a list of ICD-9 (Inter-
national Classification of Diseases, Revision 9) codes for
“birth defects and genetic disorders” for a study looking
at computerized databases of all pediatric discharges for
1 year from hospitals in CA and SC (Yoon et al. 1997).
(The codes are available as an online supplement [ap-
pendix B].) We searched our computerized data set of
discharge ICD-9 codes, using the same list of codes. The
results of this computerized search were compared to the
results of the manual chart review described above.
Descriptive statistics were calculated for total charges,
average daily charge, and length of stay. The 95% CI
was calculated for each value. Comparisons of mean
values were considered statistically significant when
there was no overlap in the calculated 95% CIs. Mi-
crosoft Excel was used for all statistical analyses.
Results
There were 9,904 admissions in 1996, of which 4,045
were excluded because they involved perinatal care, ei-
ther a teen admitted for pregnancy-related care or a ne-
onate. An additional 112 admissions (!2%) were ex-
cluded because charts were unavailable. This group was
not significantly different from the whole in terms of
charges or length of stay, as shown in table 2, although
the average age of the patients was significantly less in
those for whom charts were not available.
A total of 5,747 admissions were reviewed, repre-
senting 4,224 individuals, some of whom were admitted
more than once. Data were recorded for each admission
for those individuals. The full record was reviewed for
15,000 admissions. Data are summarized in table 3.
Figure 2 shows the number of admissions in each
category. There were 1,949 admissions in category I.
This represents ∼34% of the total admissions. The larg-
est single group, with 37% of the total admissions, was
category III, disorders with a genetically determined pre-
disposition or susceptibility. There were few admissions
in categories II and IV, birth defects and acquired dis-
orders, respectively, with no known genetic component
(2.5% combined). Finally, ∼27% of admissions were
previously healthy children (category V).
Diagnoses in Category I-A
Figure 3 shows the types of disorders in category I-A
(chromosomal and single-gene disorders). Of the 74 ad-
missions of patients with chromosomal disorders, 51
(69%) had trisomy 21, 7 (9.4%) had trisomy 13, 3 (4%)
had trisomy 18, 2 (2.7%) had sex-chromosome abnor-
malities, and 11 (14.9%) had other chromosome rear-
rangements. The 44% of admissions in the “Other” cat-
egory had one of 175 different single-gene disorders
(details available as an online supplement [appendix A]).
Length of Stay
Figure 4 shows the average length of stay for admis-
sions in each category. Children with single-gene and
chromosomal disorders (category I-A) had an average
hospital stay (7.1 d) that was twice as long as the 3.5-d
average stay for children without any preexisting chronic
medical disorder (category V). All of the other genetic
categories also had average lengths of stay that were
longer than children in category V. These differences have
nonoverlapping 95% CIs (see table 3).
Average Charge per Admission
Table 3 shows the combined charges for each of the
categories and the subgroups of category I. The differ-
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Figure 2 Admissions in each category. The same illustration
schema is used in figures 2, 4, 5, and 6. Those categories with a strong
genetic contribution (categories I and III) are shown in white. Those
categories with no genetic component, or for which there is contro-
versy (categories II and IV), are denoted by horizontal stripes. Ad-
missions of previously healthy children with no preexisting chronic
medical condition (category V) are shown in black.
Table 3
Summary of Data
Category No. of Patients
Average Age [years]
(95% CI)
Average Length of Stay [d]
(95% CI)
Average Charge
(95% CI)
I-A 622 7.7 (7.2–8.2) 7.1 (6.0–8.2) $17,218 ($13,234–$21,440)
I-B 832 5.0 (4.6–5.4) 6.4 (3.8–7.8) $17,290 ($5,647–$12,725)
I-C 495 6.1 (5.5–6.6) 4.9 (5.2–7.5) $11,413 ($14,044–$20,355)
II-A 48 2.8 (1.5–4.0) 5.8 (3.8–7.8) $9,186 ($2,274–$29,273)
II-B 19 5.8 (3.1 –8.5) 5.5 (1.5–9.5) $15,774 ($9,553–$13,273)
III 2,096 8.0 (7.8–8.3) 4.3 (3.8–4.7) $8,904 ($7,744–$10,063)
IV 72 6.8 (5.2–8.3) 7.6 (2.7–12.3) $16,857 ($6,988–$26,725)
V 1,563 6.6 (6.3–6.9) 3.5 (3.3–3.7) $6,985 ($6,306–$7,664)
I-A, I-B, I-Ca 1,949 6.1 (5.9–6.4) 6.2 (5.6–6.8) $15,774 ($13,735–$17,500)
II-A, II-Bb 67 5.4 (4.4–6.4) 5.7 (3.9–7.6) $11,054 ($5,022–$15,602)
a Represents the combination of the three subgroups of category I.
b Represents the combination of the two subgroups of category II.
ences between each subgroup of category I and category
V (no underlying condition) are highly statistically sig-
nificant, as is the difference between category III (ac-
quired disorders with genetic predisposition) and cate-
gory V. The differences in average charges between
category II subgroups and category V and between cat-
egory IV and category V do not reach statistical signif-
icance. The numbers of admissions in both categories II
and IV were small relative to the other categories, mak-
ing comparisons less meaningful. The average cost for
category IV was increased by 50% by the inclusion of
a single patient with a prolonged stay of 176 d.
Charges by Category
Figure 5 shows the total charges for each category, and
figure 6 represents the average charge per hospital day.
For the year of the study, a total of $62.3 million in
charges were generated, of which nearly $50 million
(80%) were attributed to the genetic categories (I-A, I-B,
I-C, and III), which accounted for 71% of the admissions.
The wholly genetic categories (I-A, I-B, and I-C), which
made up one-third of admissions, accounted for almost
$31 million, or 50% of the total. Add to that those chil-
dren with an underlying disorder with a genetic predis-
position (category III), and hospital expenses for children
with genetically determined illnesses accounted for nearly
$50 million, or 80% of the total hospital charges for the
year.
Diagnosis Identification Using ICD-9 Codes Only
Using the ICD-9 codes for genetic disorders defined
by Yoon et al. (1997) to search our database identified
1,490 admissions as having a genetic basis. (The codes
are available as an online supplement [appendix B].) The
diagnoses listed in that series primarily fall in our cat-
egory I. We identified 1,949 admissions in category I,
so the strategy of using a computerized search of dis-
charge ICD codes identified only 76.4% of the diagnoses
identified by a full review of the charts for clearly genetic
disorders. The computerized search of ICD-9 codes does
not include category III, a category of diseases for which
there is a strong genetically determined predisposition
or susceptibility.
Discussion
This study begins to quantify the enormous impact of
the genetic determinants of disease on inpatient pedi-
atrics and the health care system. We found that, in a
full-service pediatric inpatient facility, more than two-
thirds of admissions and 80% of the charges are attrib-
utable to diseases that have a recognized genetic com-
ponent. Children with genetically determined conditions
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Figure 3 Diagnoses included in category I-A
Figure 4 Length of stay (in days). Mean values are shown by a
bar; the vertical lines represent the 95% CIs.
also stay in the hospital longer than do children without
a preexisting chronic medical condition.
The strengths of this study are the large number of
admissions and the fact that 198% of the admissions for
a full year were reviewed for indication of an underlying
genetic component, even when it was not included in the
discharge diagnoses. This gives excellent statistical
strength to the findings and adds to the accuracy of the
results. For example, using the ICD-9 code for “chro-
mosome anomaly—not otherwise specified (NOS)” in a
computerized search would potentially classify as cate-
gory I-A patients with tumors that contain chromosomal
rearrangements. Likewise, to obtain complete data cap-
ture, this method relies on the inclusion of all possible
diagnoses in the discharge face sheet. It was clear from
our review that this was not the case. The incidence of
the discharge diagnoses inaccurately reflecting all under-
lying conditions was not recorded during the data-col-
lection phase of the study, so we cannot state with cer-
tainty the frequency of diagnoses missed by the hospital
coders in our data set. A recent study of a database of
discharge ICD-9 codes from all pediatric admissions in
CA and SC (Yoon et al. 1997) found significantly lower
numbers than those found by Hall et al. (1978) or the
current study. That study was complicated by the fact
that the researchers relied on computerized records of
billing codes, and they did not take into account complex
genetic traits and inherited predisposition/susceptibility
to disease. We searched our data set, using the list of
ICD-9 codes generated for that study. This analysis iden-
tified 1,490 admissions in our data set as having a ge-
netically determined disorder coded in the discharge
diagnoses. Since the diagnoses used primarily fit into
our category I, this strategy underestimated the true fre-
quency in our population of even that limited group of
genetic disorders by almost 25%. One could also argue
that physicians and coders in a tertiary-care children’s
hospital are more likely to accurately capture and code
genetic diagnoses than are providers in a community hos-
pital. This suggests that the strategy used by Yoon et al.
(1997) may lead to even more underascertainment in that
data set than in ours. Also, that strategy does not include
the large group of disorders that are partially genetically
determined, classified in our category III. Our analysis,
therefore, provides a more complete evaluation of the
genetic contribution to disease in the population studied.
The difficulty of applying our approach to a statewide
data set is obvious, and it is clear that both approaches
can inform the discussion of the contribution of genetics
to pediatric disease.
There are several drawbacks to the current study.
First, only inpatients in a single children’s hospital were
analyzed; second, the evaluation was done retrospec-
tively; and third, the categorization was based solely on
what the providers wrote in the charts. In spite of these
drawbacks, the findings are consistent with those of
Hall et al. (1978) from 25 years ago in an entirely dif-
ferent geographical area.
These data do not include pregnancy-related admis-
sions in teenagers, neonates, or patients admitted to the
neonatal intensive care unit, either inborn or outborn,
even though these data were available. Neonates were
excluded from the study for several reasons. First, the
purpose of the study was to determine the burden of
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Figure 5 Total charges by category. The values shown represent
millions of dollars.
Figure 6 Average charge (in dollars) per hospital day. Mean
values are shown by a bar; the vertical lines represent the 95% CIs.
genetic disease among patients admitted to the hospital
for the care of illness. Thus, there was an obvious and
real difference between the populations of pregnant
mothers and newborns admitted to the nursery and the
population admitted to the inpatient unit. The bias in-
troduced by including these patients would make the
results uninterpretable. Infants admitted to the neonatal
intensive care unit presented the opposite dilemma.
There were few, if any, admissions of “previously
healthy” infants to the neonatal intensive care unit. This
raised concern about the validity of the conclusions
drawn from the data—specifically, that children with
underlying conditions would be overrepresented in the
data. Also, as the initial review began, it became clear
that the practical difficulties of assigning the neonates
to the categories would make the current study unfeas-
ible. The neonatal intensive care unit population merits
its own study, with criteria designed specifically for that
population, as has been initially addressed by Ling et
al. (1991).
In total, 71% of patients admitted to this children’s
hospital had an underlying disorder that is known to
be at least partly genetically determined. Equally strik-
ing is the fact that, of patients with a preexisting un-
derlying condition, 196% had a disorder that was, at
least in part, genetically determined (categories I-A, I-
B, I-C, and III). Genetically determined diseases were
almost evenly divided between those that have clear-cut
genetic determinants (48.2% with single-gene, chro-
mosomal, polygenic, or multifactorial disorders) and
those for which there is a well-recognized genetically
determined predisposition (51.8%).
This information raises important issues regarding the
genetic contribution to chronic health disorders, in gen-
eral. We focused on a population of convenience—
namely, pediatric inpatients. It seems likely that the find-
ings would be similar if one were to look at chronic
diseases in a purely primary-care outpatient pediatric
population and perhaps even in an adult population.
Strategies to perform studies such as these need to be
carefully conceived to avoid the pitfalls of large, com-
puterized database searches of billing codes. That type
of study is highly dependent on coding practices and is
likely to miss many genetic disorders, particularly those
of multifactorial or polygenic inheritance, complex ge-
netic traits, or disorders with epidemiologically described
genetic predisposition.
This study confirms and updates what Hall et al.
(1978) found 125 years ago—that genetic disorders are
common, and that the cost to individuals and society
is high. Not surprisingly, the majority of children ad-
mitted to a children’s hospital have an underlying
chronic illness, and these children have longer hospital
stays and higher hospital expenses than children with-
out underlying disorders. One of the most striking find-
ings of this study is that 96% of those chronic disorders
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of childhood are partly or wholly genetically deter-
mined. We feel that this fact is not widely recognized
and that the impact is not fully appreciated by health
care providers, payers, and policy makers (Hall 1997).
Conclusions
In a children’s hospital, genetic diseases are common, not
rare. The public appears to have a strong interest in un-
derstanding the impact of new knowledge of genetics and
molecular biology on their lives and their illnesses. The
current workforce of specialty-trained genetics providers
seems insufficient to meet the expected increasing need.
In addition to a larger genetic workforce, every person
providing care to children, and to adults, will need to be
● fluent in the language of molecular biology and
genetics,
● able to grasp the complexities of genetic informa-
tion when applied to health and disease,
● competent to explain these complexities to an anx-
ious public and to discuss their implications with
affected families,
● knowledgeable about the power and potential pit-
falls of genetic testing and the implications of the
results for the individual and the family,
● informed about the promises and actualities of ther-
apies for genetic disorders, including gene trans-
fer and progenitor cell transfer approaches, and
● cognizant of the complex legal, ethical, and pri-
vacy issues raised by the characterization of an
individual’s genetic makeup.
This will require significant changes in the processes
of medical education at all levels of training and a real
commitment from health care providers to make the
effort to become conversant in genetic concepts. In the
not-so-distant future, medical practitioners will need to
be as comfortable discussing SNPs and proteomics as
they now are discussing germs and antibiotics.
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